Core Laboratories (NYSE:CLB) Shares Gap Up – Time to Buy?

Core Laboratories Inc. (NYSE:CLB) gapped up before the market opened on Tuesday . The stock had previously closed at $13.07, but opened at $13.76. Core Laboratories shares last traded at $13.53, with a volume of 20,938 shares traded.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Sunday. Weiss Ratings downgraded Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $12.00.

Core Laboratories Stock Performance

The business has a 50 day moving average of $15.87 and a 200-day moving average of $16.73. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The company has a market capitalization of $638.90 million, a P/E ratio of 21.42, a price-to-earnings-growth ratio of 2.46 and a beta of 0.99.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The business had revenue of $121.80 million during the quarter, compared to analysts’ expectations of $122.99 million. During the same period in the previous year, the business earned $0.14 earnings per share. The firm’s revenue was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, sell-side analysts predict that Core Laboratories Inc. will post 0.57 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 11th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s dividend payout ratio is presently 6.15%.

Hedge Funds Weigh In On Core Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the company. CWA Asset Management Group LLC bought a new position in shares of Core Laboratories in the fourth quarter worth approximately $9,978,000. Pacific Ridge Capital Partners LLC purchased a new stake in shares of Core Laboratories in the 3rd quarter worth about $525,000. Isthmus Partners LLC boosted its position in shares of Core Laboratories by 16.2% during the first quarter. Isthmus Partners LLC now owns 14,509 shares of the oil and gas company’s stock valued at $244,000 after purchasing an additional 2,027 shares in the last quarter. Swiss Life Asset Management Ltd purchased a new position in Core Laboratories during the 4th quarter valued at about $192,000. Finally, Abacus Wealth Partners LLC purchased a new position in Core Laboratories during the fourth quarter valued at $233,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.